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Lipid droplets (LDs), highly dynamic subcellular organelles 
primarily responsible for energy storage, have been linked to 
multiple cellular processes, including virus packing, protein 
storage and modification, and host defense (Herker et al., 2010; 
Klemm et al., 2011; Anand et al., 2012; Li et al., 2012; Suzuki 
et al., 2012). LDs contain a monolayer of phospholipids and 
their specific associated proteins, and undergo dynamic changes 
including biogenesis, fusion/growth, and degradation (Martin 
and Parton, 2006; Farese and Walther, 2009; Walther and Fa-
rese, 2012; Yang et al., 2012; Thiam et al., 2013; Pol et al., 
2014). The dynamics of LDs reflect the lipid metabolic status, 
and uncontrolled growth of LDs has been linked to the develop-
ment of multiple diseases including obesity, diabetes, fatty liver 
diseases, cardiovascular diseases, cancer, and neurodegenera-
tive diseases (Gong et al., 2009; Greenberg et al., 2011; Suzuki 
et al., 2011; Xu et al., 2012a; Krahmer et al., 2013; Gross and 
Silver, 2014; Liu et al., 2015).
LD biogenesis is initiated and nascent LDs are formed 
from ER (Murphy and Vance, 1999; Khandelia et al., 2010; 
Zanghellini et al., 2010; Gross et al., 2011; Pol et al., 2014; 
Wilfling et al., 2014; Choudhary et al., 2015). The sizes of 
nascent LDs in mammalian cells are believed to be <100 nm, 
whereas most mature cytosolic LDs have diameters ranging 
from 0.25 to 100 µm depending on cell types (Pol et al., 2014). 
Several distinct mechanisms by which LDs grow and expand 
have been discovered. First, nascent LDs may grow to mature 
ones by acquiring neutral lipids from ER through continuous 
association with ER (Ohsaki et al., 2008; Jacquier et al., 2011), 
or by incorporation of ER-synthesized lipids that is dependent 
on DGAT1 activity through an unknown mechanism (Szyman-
ski et al., 2007; Gross et al., 2011; Cartwright and Goodman, 
2012; Xu et al., 2012b; Wilfling et al., 2013). Seipin, a protein 
originally identified in human general lipodystrophy (Magré 
et al., 2001; Payne et al., 2008), has shown to play an import-
ant role in promoting LD growth (Szymanski et al., 2007; Fei 
et al., 2008, 2011; Pagac et al., 2016; Salo et al., 2016; Wang 
et al., 2016) by localizing on a potential ER–LD contact site 
(Szymanski et al., 2007; Binns et al., 2010; Grippa et al., 2015; 
Han et al., 2015; Salo et al., 2016; Wang et al., 2016). Second, 
LD-associated enzymes such as GPAT4 and DGAT2 can pro-
mote LD growth by incorporating locally synthesized TAG into 
LDs (Fujimoto et al., 2007; Kuerschner et al., 2008; Krahmer 
et al., 2011; Wilfling et al., 2013). Finally, CIDE protein can 
promote LD growth via atypical lipid transfer and LD fusion 
in the white adipose tissue, in the liver of high-fat diet treated 
or obese mice, and in skin sebocytes and lactating mammary 
epithelia cells (Gong et al., 2011; Wang et al., 2012; Zhou et 
al., 2012; Wu et al., 2014b; Zhang et al., 2014; Xu et al., 2016). 
Lipid incorporation from endoplasmic reticulum (ER) to lipid droplet (LD) is important in controlling LD growth and intra-
cellular lipid homeostasis. However, the molecular link mediating ER and LD cross talk remains elusive. Here, we identi-
fied Rab18 as an important Rab guanosine triphosphatase in controlling LD growth and maturation. Rab18 deficiency 
resulted in a drastically reduced number of mature LDs and decreased lipid storage, and was accompanied by increased 
ER stress. Rab3GAP1/2, the GEF of Rab18, promoted LD growth by activating and targeting Rab18 to LDs. LD-associated 
Rab18 bound specifically to the ER-associated NAG-RINT1-ZW10 (NRZ) tethering complex and their associated SNA REs 
(Syntaxin18, Use1, BNIP1), resulting in the recruitment of ER to LD and the formation of direct ER–LD contact. Cells with 
defects in the NRZ/SNA RE complex function showed reduced LD growth and lipid storage. Overall, our data reveal that 
the Rab18-NRZ-SNA RE complex is critical protein machinery for tethering ER–LD and establishing ER–LD contact to 
promote LD growth.
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Several factors including Perilipin, Rab8a, As160, and Mss4 
that modulate Cidec-mediated LD fusion have been identified 
(Sun et al., 2013a; Wu et al., 2014a).
The activity of RabGTPases, crucial regulators of vesi-
cle trafficking and membrane dynamics, is regulated by their 
specific GEFs, GAPs, and downstream effectors (Zerial and 
McBride, 2001; Grosshans et al., 2006; Stenmark, 2009). 
Rab18 is shown to be an LD-associated protein in several 
cell types including 3T3-L1 preadipocytes and differentiated 
adipocytes, and its expression levels and LD localization are 
controlled by specific nutritional or hormonal signals (Martin 
et al., 2005; Ozeki et al., 2005; Martin and Parton, 2008; Sal-
loum et al., 2013). Rab18 has been shown to play a potential 
role in β-adrenergic–stimulated lipolysis and in insulin-induced 
lipogenesis in adipocytes (Pulido et al., 2011) and can facil-
itate hepatitis C virus replication by interacting with its non-
structural protein NS5A (Salloum et al., 2013). Interestingly, 
point mutations (L24Q or T95R, etc.) that results in defective 
Rab18 were discovered in autosomal recessive disorder War-
burg Micro syndrome (WAR BM; Bem et al., 2011). Mutations 
in Rab3GAP1 (T18P and E24V) and Rab3GAP2 (R426C; Han-
dley and Aligianis, 2012) complex, a specific GEF for Rab18 
(Gerondopoulos et al., 2014), were also identified in patients 
suffering from WAR BM. Surprisingly, abnormal large LDs 
accumulate in fibroblasts isolated from WAR BM patients who 
harbor Rab18 or Rab3GAP1/2 mutations (Aligianis et al., 2005; 
Handley and Aligianis, 2012; Handley et al., 2013; Liegel et 
al., 2013). A recent study showed that mammalian TRA PPII 
complex may act as a GEF of Rab18 to activate and recruit it 
to LDs in several cell types (Li et al., 2017). Despite all these 
analyses, the precise mechanism by which Rab18 controls LD 
dynamics remains unclear.
The yeast Dsl1 tethering complex is stably associated with 
three ER-associated Q-SNA REs (Ufe1p, Sec20p, and Use1p 
that have a glutamine at the center of their coiled-coil domain; 
Diefenbacher et al., 2011) and believed to play a central role in 
the tethering and fusion of Golgi-derived COPI transport vesi-
cles to the ER (Andag et al., 2001; Kamena and Spang, 2004; 
Kraynack et al., 2005; Tagaya et al., 2014). Structural analysis 
revealed that the Dsl1 complex forms a 20-nm-tall “tower” from 
the ER surface (Ren et al., 2009; Tripathi et al., 2009). The NRZ 
tethering complex, the mammalian homologue of Dsl1 that in-
cludes ZW10 (Dsl1p), NAG (Dsl3p), and RINT1 (Tip20p), is 
associated with ER-localized Q-SNA REs (Use1, Syntaxin18, 
and BNIP1; Tagaya et al., 2014) and plays a potential role in 
Golgi-ER retrograde vesicle trafficking and fusion (Hatsuzawa 
et al., 2000; Burri et al., 2003; Hirose et al., 2004). Interestingly, 
a systemic screening of Rab effectors in Drosophila melanogas-
ter cells reveals that the ZW10 and RINT1 subunits of the NRZ 
complex and Syntaxin18 of the ER–SNA RE complex may be 
effectors of Rab18, and overexpression of Rab18 enhances the 
LD association of ZW10 (Gillingham et al., 2014).
Here, we have identified Rab18 as an important regula-
tor of LD dynamics as its deficiency results in a defective LD 
growth and maturation without affecting LD biogenesis. Rab-
3GAP1/2 complex, the GEF of Rab18, promotes LD growth by 
activating and targeting Rab18 to LDs. Activated Rab18 binds 
to NRZ and ER-associated Q-SNA REs and recruits them to the 
close proximity of LDs. The Rab18-NRZ-SNA RE interaction 
and complex formation result in tethering ER to LD and gener-
ating a close contact between the ER and LDs, therefore facili-
tating lipid incorporation to promote LD growth.
Results
Defective LD growth and maturation in 
Rab18-deficient cells
To identify RabGTPases that control LD dynamics, we knocked 
down 20 RabGTPases that were reported to be potentially lo-
calized to LDs in 3T3-L1 preadipocytes using their specific 
siRNAs (Wu et al., 2014a; Fig. 1 A). As control wild type or 
Rab10 knocking down cells accumulated a large number of LDs, 
knocking down Rab18 in 3T3-L1 preadipocytes led to the accu-
mulation of fewer but significantly larger LDs (Fig. 1 B and Fig. 
S1 A). Knockout (KO) of Rab18 by CRI SPR/Cas9 in 3T3-L1 
preadipocytes also resulted in the accumulation of significantly 
fewer but larger LDs (Fig. 1 C and Fig. S1 B). When Rab18 was 
reintroduced into Rab18-deficient cells, LD size was reduced 
and the number of visible LDs was increased, showing a resto-
ration of normal LD morphology (Fig. 1 C and Fig. S1 B).
To quantitatively evaluate the role of Rab18 in controlling 
LD dynamics, we systematically measured the number and 
sizes of LDs and the total volume of lipids in Rab18-deficient 
cells using a confocal optical section in combination with 3D 
surface reconstitution (Materials and methods). In control cells, 
∼99% of LDs had a diameter ranging from 0.25 µm (limits of 
the fluorescent microscope) to 2 µm when cells were treated 
with oleic acid (OA; Fig. 1 D). LDs larger than 2 µm in diameter 
were rarely observed. As nascent LDs generated from ER were 
shown to have a size ranging from 60–100 nm in diameter, these 
droplets had to subsequently grow and mature via continuous 
TAG incorporation (Zanghellini et al., 2010; Pol et al., 2014; 
Wilfling et al., 2014; Fig. 1 E). We therefore define LDs ranging 
from 0.25 to 2 µm in diameter as mature LDs, and define LDs 
larger than 2 µm in diameter as supersized LDs.
In Rab18-deficient cells, the number of mature LDs in 
each cell was dramatically decreased (117 ± 13 per cell) com-
pared with that in control cells (938 ± 105 per cell), representing 
an 88% reduction in the number of mature LDs (Fig. 1, D and 
F). The number and percentage of supersized LDs in each cell 
were significantly increased in Rab18-deficient cells (Fig. 1, D 
and G). When the sizes of the largest LD in a cell were mea-
sured in wild-type or Rab18-deficient cells, the mean diameter 
of the largest LD in Rab18-deficient cells was nearly twofold 
larger than that in control cells, representing an eightfold in-
crease in LD volume (Fig. 1 H). Quantitative analysis also con-
firmed that reintroduction of Rab18 into Rab18-deficient cells 
increased the number of mature LDs but decreased the number 
of supersized LDs (Fig. 1 H).
To monitor the dynamic LD growth process under OA 
treatment, cells were first cultured in serum-free medium over-
night to deplete existing LDs and then fed with OA. The mor-
phology of LDs was continuously recorded under a time-lapse 
microscope. In control cells, a large amount of small LDs accu-
mulated in the presence of OA. In Rab18-deficient cells, only a 
few LDs were observed, and these LDs expanded rapidly and 
grew into supersized ones (Fig. S1 C and Videos 1, 2, 3, and 4). 
Quantitative analysis of the dynamic LD growth process indi-
cated that the rate of increase in the number and the total volume 
of mature LDs in Rab18-depleted cells were significant lower 
than in control cells (Fig. S1, D and E). However, the expan-
sion of supersized LDs in Rab18-deficient cells was markedly 
faster (Fig. S1 F). The reduction of mature LD numbers and the 
appearance of supersized LDs were not a result of the fusion/
coalescence of small LDs as this was not observed during the 
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Figure 1. Defective LD growth and maturation in Rab18-deficient cells. (A) Outline of strategy to screen for LD-associated Rabs involved in LD growth. 
(B) Knocking down Rab18 alters LD morphology in 3T3-L1 preadipocytes. Bars: 10 µm; (insets) 2 µm. (C) Representative images of LDs (green) in neg-
ative control (NC) or Rab18-deficient (Rab18 KO) 3T3-L1 preadipocytes. Red represents Cherry expression. Bars: 10 µm; (insets) 2 µm. (D) Histogram 
showing the mean number of LDs in each diameter in C. Data represent mean ± SD (n = 24 cells for NC; n = 25 cells for Rab18 KO; n = 29 cells for 
Rab18 KO+Rab18; ***, P < 0.001; NS, no significance by Kruskal-Wallis test). (E) Schematic diagram showing the process of LD biogenesis and growth. 
(F–H) Quantification of the number of mature LDs under fluorescent microscope (F), the percentage of LDs in each diameter (G), and diameter of the largest 
LD in each cell (H) in C. Mean ± SD for F, mean value for G, mean ± SEM for H, n = 24 cells for NC; n = 25 cells for Rab18 KO; n = 29 cells for Rab18 
KO+Rab18; ***, P < 0.001; NS, no significance by Kruskal-Wallis test. (I) Reduced total TAG levels in Rab18 KO 3T3-L1 preadipocytes. TAG/protein level 
of control cells was normalized to 1. Three independent experiments were performed. Mean ± SD; n = 3; **, P < 0.01 by two-tailed t test. (J) Relative TAG 
level in various subcellular fractions. TAG level in PNS in control cells was normalized to 1. Three independent experiments were performed. Mean ± SD; 
n = 3; *, P < 0.05; **, P < 0.01; NS, no significance by two-tailed t test. (K and L) Increased BIP expression and mRNA levels of spliced XBP-1 in Rab18 
KO 3T3-L1 preadipocytes after OA (400 µM) treatment. Cells treated with 1 µM TG for 6 h were used as a positive control. Three independent experiments 
were performed. Mean ± SD; n = 3; *, P < 0.05; **, P < 0.01 by two-tailed t test. All experiments were performed at least twice. WT, wild type.
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live-cell imaging recording process (Video  2). Overall, these 
data strongly suggest that depletion of Rab18 disrupted normal 
LD morphology, leading to a significant reduction in the num-
ber of mature LDs but accumulation of a few supersized LDs.
Next, we measured the amount of total cellular TAG and 
its subcellular distribution in Rab18-deficient cells and observed 
significantly lower cellular TAG and reduced TAG levels in the 
LD fraction in Rab18-deficient cells after they were treated with 
OA for 20 h (Fig. 1, I and J). Similar rates of fatty acid (FA) up-
take and TAG hydrolysis were observed between wild-type and 
Rab18-deficient cells (Fig. S1, G and H). However, Rab18-defi-
cient cells had a decreased TAG synthesis (Fig. S1, I and J). As 
long-term exposure to excess FA results in a chronic ER stress 
in cells lacking the capacity to synthesize or store neutral lip-
ids (Ota et al., 2008; Chitraju et al., 2017), we evaluated the role 
of Rab18 in FA overloading–induced ER stress. As shown in 
Fig. 1 K, expression levels of Bip, a specific ER stress marker, 
were significantly increased in the presence of thapsigargin (TG), 
a known reagent to induce ER stress. The expression levels of 
Bip were also increased in Rab18-deficient cells with a prolonged 
OA treatment. Splicing levels of XBP-1, another ER stress 
marker, was also significantly increased in Rab18-deficient cells 
(Fig. 1 L). Therefore, Rab18 plays an important role in regulating 
lipid storage, and its deficiency results in reduced lipid storage 
and increased ER stress in the presence of excess free FAs.
Rab18 deficiency causes abnormal LD 
growth in adipocytes and Leydig cells
As Rab18 was previously shown to be highly expressed in dif-
ferentiated adipocytes, we knocked down Rab18 in 3T3-L1 
adipocytes and observed that these cells contained larger LDs 
compared with those in control adipocytes (Fig. 2, A and B). In 
contrast, overexpression of Rab18 in adipocytes resulted in a 
dramatic decrease in LD sizes (Fig. 2, C and D). In addition, de-
pletion of Rab18 in adipocytes led to a 20% reduction in the cel-
lular TAG levels (Fig. 2 E) and an ∼15% decrease in basal and 
stimulated lipolysis (Fig. 2 F). This minor decrease in lipolysis 
is probably a result of a secondary effect of increased LD sizes 
and decreased LD surface area in Rab18-depleted adipocytes. 
Rab18 expression is also observed in Leydig cells that contain 
large amounts of LDs and are responsible for the production 
of testosterone in testes (Yamaguchi et al., 2015; Shen et al., 
2016). We generated Rab18-deficient TM-3 (a Leydig cell line) 
cells and observed that Rab18-deficient TM-3 cells contained 
less mature LDs but an increased number of supersized LDs 
after OA treatment (Fig. 2, G and H). Overall, these data indi-
cate that Rab18 regulates the LD morphology and lipid storage 
in adipocytes and Leydig cells.
Rab18 controls the growth of nascent LDs
As Rab18 depletion dramatically reduced the number of mature 
LDs, we checked whether its deficiency would disrupt LD bio-
genesis and nascent LD formation by expressing GFP-LiveDrop, 
a nascent LD marker (Wang et al., 2016), in Rab18-deficient 
cells or in control wild-type cells. Cells were starved for 16 h 
to deplete the existing LDs. After short-term OA treatment 
(1 h), similar numbers of LiveDrop-positive LDs, representing 
nascent LDs, accumulated in both Rab18-deficient and con-
trol cells (Fig. 3, A and B). In control cells, LiveDrop-positive 
signals overlapped very well with LipidTOX (65.6%) signals 
that stain mature LDs. However, in Rab18-deficient cells, 
only a small percentage of LiveDrop positive signals (8.09%) 
overlapped with LipidTOX-positive mature LDs (Fig.  3  C). 
After cells were treated with OA for 4 h, a majority of Live-
Drop-positive LDs were also positive for LipidTOX signals in 
control cells. On the contrary, in Rab18-deficient cells, most 
LiveDrop-labeled LDs remained small and did not overlap with 
LipidTOX staining (Fig. 3 D). Therefore, Rab18 does not ap-
pear to affect LD biogenesis but is responsible for the growth 
and maturation of nascent LDs.
To further confirm the role of Rab18 in regulating the 
growth of nascent LDs, we examined LD morphology of 
Rab18-deficient cells by EM analysis. The presence of nascent 
LDs within the sizes of 100–200 nm in diameter was observed 
in both control and Rab18-deficient cells 1  h after OA treat-
ment (Fig. 3 E). Quantitative analysis indicated that the num-
ber of nascent LDs was slightly increased in Rab18-deficient 
cells compared with that in control cells (Fig.  3  F). After 
8 h of OA treatment, the total number of LDs visible in EM 
analysis showed no significant difference between control and 
Rab18-deficient cells. However, LD size distribution changed 
dramatically (Fig. 3, E, G, and H). In wild-type cells, the major-
ity of nascent LDs had grown larger than 150 nm in diameter. 
In contrast, LDs with diameter larger than 150 nm (except a 
few LDs larger than 2 µm in diameter) were rarely observed in 
Rab18-deficient cells. Instead, the majority of LDs remained 
smaller than 150 nm in Rab18-deficient cells (Fig. 3, E, G, and 
H). In summary, EM analysis confirmed that Rab18 deficiency 
did not affect LD biogenesis and nascent LD formation but con-
trolled the growth of nascent LDs into mature LDs.
Rab18-mediated LD growth and maturation 
are dependent on lipid synthesis in ER
To evaluate the role of TAG synthesis enzymes in Rab18- 
mediated LD growth, we checked the expression levels and sub-
cellular distribution of DGAT1/2 and GPAT3/4 in Rab18-deficient 
cells and found that Rab18 deficiency affected neither their ex-
pression (Fig. S2 A) nor their subcellular distribution (Fig. S2, 
B–G). Inhibition of DGAT1 activity led to the accumulation of a 
significantly lower number of mature LDs and decreased cellular 
TAG (Fig. 4, A and B; Wilfling et al., 2013) in wild-type cells 
and reduced LD sizes in Rab18-deficient cells. On the contrary, 
overexpression of DGAT1 in wild-type cells increased the number 
of mature LDs by about twofold (Fig. 4, C and D). However, over-
expression of DGAT1 in Rab18-deficient cells did not restore the 
number of mature LDs (Fig. 4, C and D). Surprisingly, inhibition 
of DGAT2 did not affect the number of mature LDs in wild-type 
cells as well as the sizes of LDs in Rab18-deficient cells (Fig. 4, 
E and F). Knocking down both GPAT3 and GPAT4, which act as 
rate-limiting enzymes in the TAG synthesis pathway upstream of 
DGAT1 and DGAT2, reduced the number of mature LDs and the 
intracellular TAG level in wild-type cells (Fig. 4, G and H) and 
decreased LD sizes in Rab18-deficient cells (Fig. 4, G and H). 
These data suggest that TAG synthesis on ER that is controlled 
by DGAT1/GPAT3/4 was responsible for the formation of super-
sized LDs, whereas local TAG synthesis mediated by DGAT2 
did not contribute to the formation of supersized LDs in Rab18- 
deficient cells. Consistent with Chitraju et al. (2017), we observed 
increased FA overloading–induced ER stress in wild-type cells 
when DGAT1 was inhibited (Fig. 4 I). In Rab18-deficient cells, 
ER stress was induced under the FA overloading condition and 
further enhanced when DGAT1 (but not DGAT2) was inhibited 
(Fig.  4  I). Overall, we demonstrated that Rab18-mediated LD 
growth and maturation are dependent on TAG synthesis on ER, 
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and Rab18 may play a role in mediating the transfer of ER-syn-
thesized lipids to nascent LDs.
Rab3GAP1/2 controls the activity and LD 
localization of Rab18
To delineate the mechanism by which Rab18 controls LD 
growth, we checked its subcellular localization and observed 
that endogenous Rab18 was associated with LDs in 3T3-L1 
preadipocytes (Fig.  5  A). Biochemical fractionation further 
confirmed that Rab18 was highly enriched in the LD fraction 
(Fig. 5 B). In serum-free medium, Rab18 was observed at spe-
cific loci on ER and associated with nascent LDs when cells 
were treated with FAs, overlapping with ACSL3, an early LD 
marker (Kassan et al., 2013; Fig. 5 C). Rab3GAP1/2 complex, a 
GEF of Rab18, was also localized to LD when Rab3GAP2 was 
coexpressed with Rab18 in 3T3-L1 preadipocytes (Fig. 5 D). 
Colocalization of Rab3GAP1, Rab3GAP2, and Rab18 was 
also observed at the newly synthesized LDs (Fig. S3 A). When 
Rab18 was introduced into Rab3GAP1- or Rab3GAP2-deficient 
cells, the LD localization of Rab18 was completely abolished in 
these cells (Fig. 5 E and Fig. S3 B). Biochemical fractionation 
also showed that the enrichment of Rab18 on LD fraction was 
abolished in cells deficient in Rab3GAP1 (Fig. 5 F).
We then checked the LD morphology in Rab3GAP1- or 
Rab3GAP2-deficient 3T3-L1 preadipocytes (Fig. 5 G; and Fig. 
S3, B and C) and observed that the number and percentages of 
mature LDs in these cells were dramatically reduced (41 ± 2 
per cell in GAP1 KO cells or 33 ± 1 per cell in GAP2 KO cells 
vs. 612 ± 28 per cell in wild-type cells, representing a nearly 
95% reduction; Fig. 5, G and H; and Fig. S3, C and D). Instead, 
both Rab3GAP1- and Rab3GAP2-deficient cells accumulated 
supersized LDs (Fig. 5, G and H; and Fig. S3, C, E, and F), 
Figure 2. Rab18 deficiency causes abnormal LD growth in adipocytes and Leydig cells. (A and B) Knocking down Rab18 alters LD (green) sizes in ad-
ipocytes. Bars: 10 µm; (insets) 5 µm. (B) Size distribution of the largest LD. LDs from 88 siRab18-transfected cells and 116 siNC-transfected cells were 
analyzed (pooled from three experiments). LD size distribution was fitted with Gaussian function. (C and D) Overexpressing Rab18 decreases LD sizes in 
adipocytes. Green, GFP; red, LDs. Bars: 10 µm; (insets) 5 µm. (D) The size distribution of the largest LD. LDs from 121 Rab18-transfected cells and 100 
vector-transfected cells were analyzed (pooled from three experiments). LD size distribution was fitted with Gaussian function. (E) Relative cellular TAG levels 
in adipocytes. TAG/protein level of siNC was normalized to 1. Three independent experiments were performed. Mean ± SD; n = 3; ***, P < 0.001 by 
two-tailed t test. (F) Reduced basal and stimulated lipolysis in Rab18 knockdown adipocytes. The amount of free glycerol released from siNC cells without 
the treatment of isoproterenol (iso) and 3-isobutyl-1-methylxanthine (IBMX) was normalized to 1. Three independent experiments were performed. Mean 
± SD; n = 3; **, P < 0.01; ***, P < 0.001 by one-way ANO VA with Tukey post hoc tests. (G and H) Rab18 deficiency in TM-3 Leydig cell alters LD 
morphology. Green, LDs. Bars: 5 µm; (insets) 2 µm. (H) Histogram showing the mean number of LDs in G. Mean ± SD; n = 10; ***, P < 0.001; NS, no 
significance by two-tailed t test. All experiments were performed at least twice.
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similar to those in Rab18-deficient cells. Consistent with re-
duced mature LDs, the total amount of cellular TAG in these 
cells was also decreased (Fig. S3 G). In mature adipocytes, both 
Rab3GAP1 and Rab3GAP2 were markedly increased during 
the course of adipocyte differentiation (Fig. S3 H) and colo-
calized with Rab18 on LDs, consistent with the observation in 
preadipocytes (Fig. S3 I). Rab3GAP1 deficiency in adipocytes 
did not affect 3T3-L1 differentiation as the expression levels 
of FABP4, Plin1, and Fsp27 were similar between wild-type 
and Rab3GAP1-deficient cells (Fig. S3 J). Similar to the ob-
servation in Rab18-deficient adipocytes, Rab3GAP1-deficient 
adipocytes accumulated fewer but larger LDs (Fig. 5 I and Fig. 
S3 K). Overall, these data strongly indicate that Rab3GAP1/2 
acts as a GEF to promote the LD localization and activation 
Figure 3. Rab18 controls the growth of nascent LDs. (A–C) Similar number of nascent LDs labeled with GFP-LiveDrop in control and Rab18 KO cells. 
Green, GFP-LiveDrop; red, LipidTOX neutral red. Circles, LipidTOX-positive LDs; dotted line circles, LipidTOX-negative LDs. Bars: 5 µm; (insets) 2 µm. 
(B) Quantification of the number of LiveDrop-positive LDs and LipidTOX-positive LDs. Mean ± SD; n = 10 for control cells, n = 11 for Rab18 KO cells; NS, 
no significance; ***, P < 0.001 by two-tailed t test. (C) The percentage of LDs that were LiveDrop-positive but LipidTOX-negative. Mean ± SD; n = 10 for 
control cells, n = 11 for Rab18 KO cells; ***, P < 0.001 by Mann-Whitney test. (D) Representative images showing LiveDrop-positive (green) LDs in cells 
treated with OA for 4 h. Red, LipidTOX neutral red. Bars: 5 µm; (insets) 2 µm. (E) Representative EM images showing the LD morphology in Rab18 KO and 
in control 3T3-L1 preadipocytes. Red arrows, the nascent LDs; orange arrows, the mature LDs; blue arrows, the supersized LDs. Bars, 500 nm. (F) Number 
of LDs in randomly selected EM image fields in cells treated with OA for 1 h in E. Mean ± SD; n = 147 ROIs for control cells, n = 154 ROIs for Rab18 KO 
cells; ***, P < 0.001 by Mann-Whitney test. (G and H) Total number of LDs (G) and the mean number of LDs in each diameter in cells (H) that were treated 
with OA for 8 h in E. Mean ± SD; n = 22 ROIs for control cells, n = 29 ROIs for Rab18 KO cells; **, P < 0.01; ***, P < 0.001; NS, no significance by 
Mann-Whitney test. All experiments were performed at least twice.
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Figure 4. TAG synthesis on ER is required for 
Rab18-controled LD growth. (A and B) Inhibi-
tion of DGAT1 activity reduced the size and 
number of LDs in both control (NC) and Rab18 
KO cells. 1  µM of DGAT1 inhibitor (DGAT1 
in.) was used. Green, LDs. Bars: 10 µm; (in-
sets) 2 µm. Histogram in B showing the mean 
number of LDs in each diameter in A. Mean 
± SD; n = 11–18 for each genotype; *, P < 
0.05; ***, P < 0.001; NS, no significance 
by two-tailed t test. (C and D) Rab18 KO cells 
expressing DGAT1 did not accumulate mature 
LDs. Red, LDs. Bars: 5 µm; (insets) 2 µm. Histo-
gram in D showing the mean number of LDs in 
each diameter in C. Mean ± SD; n = 19–28 
cells for each genotype; *, P < 0.05; **, P < 
0.01; ***, P < 0.001; NS, no significance by 
two-tailed t test. (E and F) Inhibition of DGAT2 
did not affect the numbers and sizes of LDs in 
Rab18 KO cells. 2 µM of DGAT2 inhibitor was 
used. Bars: 10 µm; (insets) 2 µm. Histogram 
in F showing the mean number of LDs in each 
diameter in E. Mean ± SD; n = 9–11 for each 
genotype; *, P < 0.05; NS, no significance 
by two-tailed t test. (G and H) Knocking down 
GPAT3/4 reduced the number and sizes of 
mature LDs in Rab18 KO cells. Bars: 5 µm; (in-
sets) 2 µm. Histogram in H showing the mean 
number of LDs in each diameter in G. Mean 
± SD; n = 10; *, P < 0.05; ***, P < 0.001; 
NS, no significance by two-tailed t test. (I) Re-
duced TAG and increased ER stress in Rab18 
KO cells treated with FAs. Left: Representative 
Western blot showing the ER stress in Rab18 
KO cells. From three independent experiments. 
Right: Subcellular TAG levels of one repre-
sentative experiment. All experiments were 
performed at least twice.
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Figure 5. Rab3GAP1/2 controls the activity and LD localization of Rab18. (A) Endogenous Rab18 (green) was associated with LDs (red) in 3T3-L1 
preadipocytes. Bars: 10 µm; (insets) 2 µm. (B) Rab18 was enriched in LD fraction isolated from 3T3-L1 preadipocytes. ADRP, LD marker; GRP94, a mic-
rosomal marker; β-tubulin, a cytosol marker. (C) Rab18 (green) was associated with LD (blue) at early stage of LD biogenesis. Red, endogenous ACSL3. 
Bars: 10 µm; (insets) 2 µm. (D) Representative SIM superresolution images showing the localization of HA-Rab3GAP2 (red) and GFP-Rab18 (green) on LDs 
(blue). Bars: 10 µm; (insets) 1 µm. (E) Rab18 (green) was not localized to LDs (blue) in Rab3GAP1- or Rab3GAP2-deficient cells. Red, ACSL3. Bars: 10 µm; 
(insets) 2 µm. (F) Rab18 was not enriched in the LD fraction in Rab3GAP1-deficient cells. (G and H) Reduced mature LDs and the presence of supersized LDs 
in Rab3GAP1/2-deficient cells. Bars: 10 µm; (insets) 2 µm. Histogram in H showing the mean number of LDs in each diameter in G. Mean ± SD; n = 13 for 
control cells, n = 20 for Rab3GAP1 KO cells, n = 16 for Rab3GAP2 KO cells; ***, P < 0.001 by one-way ANO VA with Tukey post hoc tests. (I) Increased 
LD (green) sizes in Rab3GAP1-deficient adipocytes. Bars: 10 µm; (insets) 5 µm. All experiments were performed at least twice. 
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of Rab18 in controlling LD growth and maturation in both 
pre- and mature adipocytes.
Rab18 binds to ZW10 and forms a 
complex with NRZ tethering proteins
Because NRZ tethering complex that comprises NAG, RINT1, 
and ZW10 has been reported to interact with Rab18 (Gilling-
ham et al., 2014), we further confirmed their interaction by 
overexpressing FLAG-Rab18 and checked the presence of en-
dogenous NRZ proteins in the Rab18–immunoprecipitation (IP) 
products. Endogenous NAG and ZW10 were detected in the 
precipitates (Fig. 6 A). The amount of coprecipitated NAG and 
ZW10 was increased in the presence of Rab3GAP1/2. RINT1, 
the third component in the NRZ complex, was also detected 
in the Rab18-IP product in the presence of Rab3GAP1/2 
(Fig.  6  A). To test the interaction of Rab18 with individual 
subunits in the NRZ complex, we first coexpressed ZW10 and 
Rab18 in 293T cells, and observed that ZW10 and Rab18 were 
able to reciprocally pull down each other (Fig.  6, B and C). 
To ascertain the direct interaction between Rab18 and ZW10, 
we purified Flag-ZW10 from 293T cells and GST-Rab18 from 
Escherichia coli (Fig. S4 A) and performed in vitro binding as-
says. As shown in Fig. 6 D, GST-Rab18 was able to specifically 
pull down ZW10 in the presence of GTPγS that locked Rab18 
in its GTP-bound form. We then generated serial truncations of 
ZW10 and identified that its C terminus was necessary for its 
interaction with Rab18 (Fig. S4, B and C). ZW10 truncation 
lacking the C-terminal region still bound to NAG and RINT1, 
consistent with previous observation (Arasaki et al., 2006) that 
the N-terminal region of ZW10 mediates its interaction with 
NAG/RINT1. NAG alone showed weak interaction with Rab18, 
and its association with Rab18 was dramatically increased in 
the presence of ZW10 (Fig. 6 E). Truncation analysis further 
revealed that the C-terminal region (aa 1355–2371) of NAG 
mediated its interaction with ZW10 and Rab18 (Fig. 6 E and 
Fig. S4 D). These data suggest that ZW10 in the NRZ complex 
interacts directly with the GTP-bound form of Rab18, and its 
C-terminal region is essential for this interaction.
To check whether Rab18 affects the subcellular distribu-
tion of NRZ complex, we first isolated various subcellular frac-
tions from wild-type or Rab18-deficient TM-3 cells (Fig. 6 F). 
Components of NRZ complex including ZW10 and NAG were 
detected in both ER and LD fractions in wild-type cells. How-
ever, their presence in the LD fraction was completely abolished 
in the absence of Rab18. When Cherry-ZW10 and HA-Rab18 
were coexpressed in 3T3-L1 preadipocytes, both endogenous 
NAG and Cherry-ZW10 were observed on the LD surface, 
colocalizing with Rab18 (Fig.  6  G). In addition, introduction 
of Rab18 into 3T3-L1 preadipocytes markedly enhanced the 
LD localization of endogenous NAG and ZW10 (Fig.  6  H). 
RINT1 was also observed on the LD surface (Fig. S4 E). When 
GFP-ZW10 was introduced into mature adipocytes, the LD as-
sociation of ZW10 was observed only when it was coexpressed 
with wild-type Rab18 but not with Rab18-C203A (Fig. S4 F). 
These data indicate that Rab18, in its GTP-bound form, inter-
acts with and recruits the NRZ complex to the LD surface.
NRZ tethering complex act as a 
downstream effector of Rab18 to 
control LD growth
To evaluate the function of the NRZ complex in regulating LD 
growth, we knocked out NAG or ZW10 in 3T3-L1 preadipocytes 
(Fig. S5 A). Depletion of NAG or ZW10 led to the accumulation 
of significantly fewer but larger LDs (Fig. 7 A). Quantitative 
analysis of LD morphology showed that NAG or ZW10 defi-
ciency resulted in a dramatic reduction in the number and per-
centage of mature LDs after OA treatment (218 ± 6 per cell in 
NAG-deficient cells or 297 ± 19 per cell in ZW10-deficient cells 
vs. 557 ± 22 per cell in wild-type cells, representing a nearly 
50% reduction; Fig. 7, B and C; and Fig. S5 B). On the con-
trary, numbers of supersized LDs were significantly increased 
in NAG- or ZW10-deficient cells (Fig. 7 B and Fig. S5, B and 
C). Similar to the observation in Rab18-deficient cells, time-
lapse imaging showed that NAG-deficient cells accumulated a 
few large LDs that expanded rapidly (Fig. S5, D–G; and Videos 
5 and 6). In addition, levels of total cellular TAG were signifi-
cantly decreased in NAG- or ZW10-deficient cells (Fig. 7 D), 
and the susceptibility of long-term FA–induced ER stress was 
increased in NAG-deficient cells (Fig. 7 E). In addition, over-
expressing Rab18 in NAG-deficient cells did not increase the 
number of mature LDs (Fig. 7, F and G) or decrease the size of 
supersized LDs (Fig. 7, F and H). Importantly, when truncated 
ZW10 that is defective in interacting with Rab18 was intro-
duced into ZW10-deficient cells (Fig. S5 H), it did not restore its 
function in promoting LD growth and maturation (Fig. S5, I and 
J). These data indicate that NRZ complex acts downstream of 
Rab18, and the interaction between Rab18 and NRZ is crucial 
for its role in promoting LD growth and maturation.
To test whether NAG controls LD biogenesis, we ex-
pressed GFP-LiveDrop in wild-type or NAG-deficient cells. 
4 h after OA treatment, the majority of LiveDrop-positive LDs 
overlapped with LipidTOX in wild-type cells. In NAG-deficient 
cells, a large number of LiveDrop-positive LDs accumulated, 
and they did not overlap with the LipidTOX signal (Fig. S5 
K). EM analysis showed that nascent LDs <150 nm in diame-
ter were present in both wild-type and NAG-deficient cells 1 h 
after OA treatment (Fig. 7 I), and the number of nascent LDs 
was slightly increased in NAG-deficient cells (Fig. 7 J). After 
prolonged OA treatment (8 h), the total number of LDs visi-
ble in EM analysis showed no significant difference between 
wild-type and NAG-deficient cells (Fig. 7, I and K). However, 
in NAG-deficient cells, the majority of LDs had a diameter less 
than 150 nm, and a few supersized LDs were observed (Fig. 7, I 
and L). These data indicate that NAG deficiency does not affect 
LD biogenesis but controls the growth of nascent LDs to form 
mature LDs, almost completely recapitulating the phenotype of 
Rab18 and Rab3GAP1/2 deficiencies.
ER-associated SNA REs control Rab18-
mediated LD growth
As the NRZ complex has been reported to interact with ER- 
associated Q-SNA REs including Syntaxin18, Use1, and BNIP1 
(Hatsuzawa et al., 2000; Hirose et al., 2004; Nakajima et al., 
2004), we tested whether these proteins play roles in regulat-
ing LD growth by knocking them out in 3T3-L1 preadipocytes 
(Fig. 8 A). A loss of any member of the Q-SNA REs resulted 
in a reduction of the accumulation of mature LDs (110 ± 3 per 
cell in Stx18 KO cells, 166 ± 5 per cell in Use1 KO cells, and 
161 ± 7 per cell in BNIP1 KO cells vs. 593 ± 24 per cell in 
wild-type cells, representing a nearly 75% reduction; Fig.  8, 
B–D), whereas the number of supersized LDs was significantly 
increased and levels of cellular TAG were markedly reduced 
in Stx18-, Use1-, or BNIP1-deficient cells after prolonged OA 
treatment (Fig. 8, B, E, and F). As three Q-SNA REs and one 
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Figure 6. Rab18 binds to NRZ tethering complex. (A) Rab18 interacted with NRZ complex. (B and C) Rab18 interacted with ZW10. (D) ZW10 interacted 
with GTP-bound Rab18 in vitro with a higher affinity. (E) ZW10 enhanced the interaction between Rab18 and NAG. Right: Schematic diagram showing 
the interaction pattern between Rab18 and NRZ complex. (F) The LD association of NAG and ZW10 was dependent on Rab18. Subcellular fractions were 
isolated from control or Rab18-deficient TM-3 cells. ADRP, GRP94, GM130, and β-tubulin represent LD, microsomal, Golgi, and cytosolic markers, respec-
tively. (G) Colocalization of HA-Rab18 (pink), Cherry-ZW10 (red), and endogenous NAG (green) on LDs (blue). Bars: 10 µm; (insets) 2 µm. (H) Association 
of endogenous ZW10 (green) or endogenous NAG (green) with LDs (blue) in the presence of Rab18 (red). Bars: 10 µm; (insets) 2 µm. All experiments 
were performed at least twice. FL, full-length.
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Figure 7. NRZ complex acts as a downstream effector of Rab18 to control LD growth. (A–C) Increased supersized LDs and reduced mature LDs in NAG- 
deficient (NAG KO) and ZW10-deficient (ZW10 KO) 3T3-L1 preadipocytes. Bars: 10 µm; (insets) 2 µm. (B) The mean number of LDs in each diameter in A.  
(C) Quantification of the number of mature LDs per cell in A. Mean ± SD; n = 13 for control cells, n = 22 for NAG-deficient cells, n = 20 for ZW10-deficient 
cells; ***, P < 0.001 by one-way ANO VA with Tukey post hoc tests. (D) Reduced cellular TAG levels in NAG KO- and ZW10 KO 3T3-L1 preadipocytes. 
Three independent experiments were performed. Mean ± SD; n = 3; *, P < 0.05; **, P < 0.01 by one-way ANO VA with Tukey post hoc tests. (E) Increased 
ER stress in NAG KO cells after long-term OA treatment (400 µM). Cells treated with 1 µM TG for 6 h were used as a positive control. (F–H) Introduction of 
Cherry-Rab18 (red) into NAG KO cells did not restore its function in the accumulation of mature LDs. (F) Representative images of LD morphology. LDs were 
stained with Bodipy 493/503. Green, LDs; red, Cherry. Bars: 10 µm; (insets) 2 µm. (G) Quantification of the number of mature LDs in each cell Mean ± 
SD; n = 25 cells for vector-transfected cells, n = 27 cells for Rab18-transfected cells; NS, no significance by Mann-Whitney test. (H) Quantification of the 
size of the largest LD in each cell Mean ± SEM; n = 31 cells for vector-transfected cells, n = 33 cells for Rab18-transfected cells; NS, no significance by 
two-tailed t test. (I) Representative EM images showing LD morphology in control and NAG KO 3T3-L1 preadipocytes. Bars, 500 nm. (J) The total number of 
LDs in each cell treated with OA for 1 h was increased. Mean ± SD; n = 137 ROIs for control cells, n = 154 ROIs for NAG-deficient cells; ***, P < 0.001 
by Mann-Whitney test. (K and L) Defective LD growth and maturation in NAG KO cells treated with OA for 8 h. Number of LDs (K) and histogram of the 
mean number of LDs (L) in each diameter in cells treated with OA for 8 h in K. Mean ± SD; n = 25 ROIs for control cells, n = 29 ROIs for NAG-deficient 
cells; ***, P < 0.001; NS, no significance by Mann-Whitney test. All experiments were performed at least twice.
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R-SNA RE (that has an arginine at the center of its coiled-coil 
domain) are required to trigger typical membrane fusion, we 
isolated several potential R-SNA REs including Sec22b, Ykt6, 
and Vamp8 from LD fraction of the liver of ob/ob mice (Table 
S1). Knocking down Sec22b or Vamp8 did not affect LD mor-
phology (Fig. 8, G and H). Knocking down Ykt6 led to a very 
minor effect in LD sizes and numbers (Fig. 8, G and H).
Consistent with its function in controlling LD growth, 
ER-associated Q-SNA REs were detected in the Rab18-IP com-
plex (Fig. 8 I). Expression of Rab3GAP1/2 further enhanced the 
association of Rab18 with these SNA REs (Fig. 8 I). Biochemi-
cal fractionation showed that Stx18, Use1, and BNIP1 were all 
present in both ER and LD fractions in wild-type cells, but their 
presence in LD fraction was completely abolished in Rab18- 
deficient cells (Fig.  8  J). In addition, when Stx18, Use1, or 
BNIP1 was coexpressed with Rab18, they all showed in close 
proximity to LDs (Fig.  8  K). The LD association of ER- 
associated Q-SNA REs was dependent on the NRZ complex as 
NAG deficiency dramatically abolished their LD association 
(Fig. 9 A). GFP-Use1, when coexpressing with HA-Rab18, was 
recruited to LDs in 80% of wild-type cells, but its LD asso-
ciation was only observed in less than 20% NAG- or ZW10- 
deficient cells (Fig. 9, B and C). Surprisingly, Ykt6 interacted 
with neither Rab18 (Fig. 8 I) nor Stx18/Use1/BNIP1 Q-SNA REs 
(not depicted). In addition, it was not localized to LD, either 
(Fig. 8 J). Therefore, ER-associated Q-SNA REs are important 
in controlling LD growth and lipid storage by forming a com-
plex with Rab18/NRZ tethering complex. The role of R-SNA 
RE Ykt6 in Rab18-mediated LD growth remains unclear.
Rab18/NRZ/SNA RE complex establishes an 
ER–LD contact
As Stx18, Use1, and BNIP1 are ER membrane–integrated pro-
teins, we hypothesize that the recruitment of these SNA REs 
to the LD surface may result in the recruitment of ER mem-
brane to the LD surface to create a close contact between ER 
and LDs. Indeed, when CB5, an ER-specific protein, was co-
expressed with Rab18 and BNIP1 in 3T3L1-preadipocytes, 
BNIP1-positive signals were almost completely colocalized 
with CB5 and Rab18 on the LD surface in approximately 80% 
of cells (Fig.  9, D and E), but in NAG-deficient cells the co-
localization of CB5/BNIP1 (ER-positive) signals and Rab18 
(LD-associated) signals was significantly abolished (observed 
in less than 20% of the cells; Fig.  9, D and E). The colocal-
ization between ER and LD was also observed when another 
ER-specific protein, RFP-KDEL, was coexpressed with GFP-
Use1 and HA-Rab18 (Fig. 9 F).
To directly visualize ER–LD contact, we coexpressed 
GFP-Stx18 and APEX-GBP (GFP binding protein) in wild-
type, Rab18-overexpressing, and Rab18-deficient 3T3-L1 
preadipocytes. As APEX catalyzes the formation of a high-elec-
tronic-density substance in the presence of DAB and OsO4 
(Ariotti et al., 2015), the ER-localized Stx18 was observed 
as a higher density signal. Consistent with the fluorescent 
imaging analysis (Fig.  9, D and F), EM images showed that 
APEX-Stx18–positive ER cisternae were clearly observed in 
Rab18-overexpressing cells (Fig.  10  A). Moreover, multiple 
APEX-Stx18–positive signals were observed on the LD sur-
face, indicating multiple direct contacts between ER and LD 
(Fig.  10  A, red arrows). Quantitative analysis showed that 
nearly 80% cells overexpressing Rab18 had at least one LD 
that was labeled with multiple condensed APEX-Stx18 signals 
(Fig. 10, A and B). Approximately 10% cells showed a single 
APEX-Stx18 positive signal on the LD surface in control wild-
type cells, indicating a single ER–LD contact (Fig. 10, A and 
B). In Rab18-deficient cells, less than 2.5% cells contained such 
ER–LD contact (Fig. 10, A and B).
Furthermore, we also measured the presence of ER mem-
brane near the LD surface (within the distance of 20 nm) as an 
indirect criterion of a potential ER–LD. In Rab18-overexpress-
ing cells, nearly 60% LDs were apposed to ER membrane, and 
33% of total LD surface area had ER membrane apposed to it. 
In control wild-type cells, ∼30% LDs showed ER apposition 
and 5% total LD surface area was apposed to ER membrane. In 
Rab18-deficient cells, less than 5% LDs showed ER apposition, 
and 1% of total LD surface area was apposed to ER membrane 
(Fig. 10, C and D). These data demonstrate that Rab18 controls 
a direct ER–LD contact and LD apposition to ER membrane.
Overall, our data indicate that Rab18 is able to recruit 
the NRZ protein complex and its associated ER–SNA REs to 
the close proximity of LD to form a close LD-ER contact-
ing site that potentially enhances lipid transfer from ER to 
LD to promote LD growth.
Discussion
LDs serve as lipid storage depots, and their dynamic changes, 
including biogenesis and growth, are important in regulating 
lipid homeostasis. Here, we show that Rab18, a LD-associated 
RabGTPase, plays a key role in controlling LD growth and mat-
uration by interacting with its effector, the NRZ/SNA RE tether-
ing protein complex, resulting in the initiation of close contact 
between ER and LD and facilitation of the incorporation of 
ER-synthesized lipids to LDs for their growth.
One of the most prominent features in Rab18-deficient fi-
broblast cells is the disappearance of normal-sized LDs and the 
appearance of a few supersized LDs. A similar role for Rab18 is 
also observed in mature adipocytes and in Leydig cells. Rab18 
deficiency in 3T3-L1 preadipocytes did not affect nascent LD 
biogenesis, lipolysis, FA uptake, and LD coalescence. TAG syn-
thesis in Rab18-deficient 3T3-L1 preadipocytes was reduced. 
As we did not observe a difference in their expression levels and 
subcellular distribution of TAG synthesis enzymes in Rab18-de-
ficient cells, the lower TAG synthesis may be a result of a sec-
ondary effect of defective LD growth. Rab18 was previously 
shown to control lipolysis in adipocytes (Pulido et al., 2011). 
We also observed a slight decrease in both basal and stimulated 
lipolysis in Rab18-deficient adipocytes. This is likely a result 
of a secondary effect of a decreased surface-to-volume ratio of 
LDs and the cellular TAG level. The formation of supersized 
LDs in Rab18-deficient cells may be a result of redirection of 
lipids from ER to a subset of LDs. Change of LD morphology 
was not observed in Rab18-deficient AML12, HeLa, Cos7, and 
293T cells (unpublished data), indicating a cell type–specific 
role of Rab18 in controlling lipid storage and LD growth. In-
terestingly, although we observed similar expression levels of 
Rab18, Rab3GAP1/2, and NRZ/SNA REs in these cells to that 
in 3T3-L1 preadipocytes, the LD association of Rab18 was 
greatly enhanced in 3T3-L1 pre- and differentiated adipocytes 
and in Leydig cells (unpublished data). The distinct localization 
of Rab18 may account for its role in controlling LD growth and 
maturation. Alternatively, other RabGTPases may play a func-
tionally redundant role in controlling LD growth in these cells.
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Figure 8. ER-associated SNA REs control LD growth by interacting with Rab18/NRZ. (A–D) KO ER-associated Q-SNA REs (Stx18, Use1, and BNIP1) in 
3T3-L1 preadipocytes led to defective LD growth and the accumulation of supersized LDs. (A) Western Blot showing the expression level of indicated pro-
tein in 3T3-L1 preadipocytes. (B) Representative images of LD morphology. Bars: 10 µm; (insets) 2 µm. (C) Histogram showing the number of LDs in each 
diameter in B. (D) Quantification of the number of mature LDs in B. Mean ± SD; n = 15–20 for each genotype; ***, P < 0.001 by one-way ANO VA with 
Tukey post hoc tests. (E) The size distribution of the largest LD in each cell in B. The diameters of LDs from 218–252 cells/genotype (pooled from three 
experiments) were fitted with Gaussian function. (F) Reduced cellular TAG levels in Stx18-deficient, Use1-deficient, or BNIP1-deficient 3T3-L1 preadipocytes. 
Three independent experiments were performed. Mean ± SD; n = 3; ***, P < 0.001 by one-way ANO VA with Tukey post hoc tests. (G) LD morphology in 
3T3-L1 preadipocytes knocking down R-SNA REs (Sec22b, Ykt6, and Vamp8). Green, LDs. Bars: 10 µm; (insets) 2 µm. (H) The LD size distribution in G. The 
diameters of LDs from 97–206 cells/genotype (pooled from three experiments) were fitted with Gaussian function. (I) Rab18 interacts with ER-associated 
Q-SNA REs. (J and K) The LD association of ER-associated Q-SNA REs is dependent on Rab18 by biochemical fractionation (J) and imaging (K) analyses. 
Subcellular fractions were isolated from control or Rab18 KO TM-3 cells. In K, Q-SNA REs, LD, and Cherry-Rab18 were labeled green, blue, and red, 
respectively. Bars: 10 µm; (insets) 2 µm. All experiments were performed at least twice.
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The LD localization and activity of Rab18 is controlled 
by its GEFs, Rab3GAP1/2, as Rab3GAP1/2 is colocalized 
with Rab18 on LDs and their depletion abolishes the LD as-
sociation of Rab18 and results in the loss of mature LDs and 
reduction in lipid storage. As Rab3GAP1/2 is also shown to 
be responsible for the ER localization of Rab18 in COS7 cells 
and may regulate ER tubulation (Gerondopoulos et al., 2014), 
the localization and function of Rab18 and its GEF could 
be cell type dependent.
Importantly, we found that the GTP-bound form of Rab18 
interacts directly with the C-terminal region of ZW10, one of 
the subunits of the NRZ tethering factors. In addition, NRZ 
complex and its associated Q-SNA REs form a protein complex 
with Rab18. Therefore, ZW10 acts as a bridge to recruit the NRZ 
tethering complex and its associated Q-SNA REs to Rab18. Func-
tionally, NRZ and its associates, Q-SNA REs, act downstream of 
Rab18 to control LD growth, lipid storage, and FA-overloading–
induced ER stress, almost a complete recapitulation of the role 
Figure 9. Rab18/NRZ/SNA RE complex establishes ER–LD contact. (A) Presence of ER-associated SNA REs in LD fraction is dependent on NAG. Subcellu-
lar fractions were isolated from control or NAG KO 3T3-L1 preadipocytes. (B and C) Use1 (green) was colocalized with Rab18 (red) to LDs (blue) in the 
control but not in NAG KO or ZW10 KO 3T3-L1 preadipocytes. Bars: 5 µm; (insets) 2 µm. (C) Quantitative analysis. Cells with Rab18 were selected for 
calculation and LDs with GFP-Use1 localization were counted as positive. Three independent experiments were performed. Mean ± SD; n = 3; ***, P < 
0.001; NS, no significance by one-way ANO VA with Tukey post hoc tests. (D) Colocalization of CB5 (green, an ER-associated protein), Rab18 (red), and 
BNIP1 (pink) on LDs in wild-type but not in NAG KO cells. Bars: 10 µm; (insets) 2 µm. (E) Quantification of percentage of cells containing CB5 positive LDs 
in D. Rab18-positive cells were selected for calculation. Three independent experiments were performed. Mean ± SD; n = 3; ***, P < 0.001 by two-tailed 
t test. (F) Colocalization of GFP-Use1 (green), RFP-KEDL (red, an ER-specific marker) and HA-Rab18 (pink) on LDs. 3D view of indicated channels are shown 
in xy, xz, or yz direction. Bars: 10 µm; (insets) 2 µm. All experiments were performed at least twice.
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Figure 10. Tethering LDs to ER by Rab18/NRZ/SNA RE complex controls LD growth. (A) Representative EM images showing a close contact between ER 
and LD in Rab18 overexpressing cells. ER cisternae are indicated with blue arrow; ER–LD contact sites are indicated with red arrows. Bars: (1–5) 500 nm; 
(6) 1 µm; (insets) 100 nm. (B) Quantification of percentage of cells containing APEX-Stx18–positive ER–LD contact (22–39 cells/genotype, pooled from two 
experiments). (C) Quantification of percentage of LDs apposing to ER per ROI. Mean ± SD; n = 11–17 ROIs/genotype; ***, P < 0.001 by two-tailed t test. 
(D) Quantification of percentage of LD surface area apposing to ER per ROI. Mean ± SD; n = 11–17 ROIs/genotype; ***, P < 0.001 by Mann-Whitney 
test. (E) Working model: Rab18-GTP binds to the NRZ tethering complex and its associated Q-SNA REs to recruit ER to the close proximity of LDs to create 
a contact between ER and LDs, allowing the transfer of TAG from ER to LDs at the interface of ER–LD to promote nascent LD growth. All experiments were 
performed at least twice. O.E., overexpression.
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of Rab18. Unlike the membrane fusion mediated by Q-SNA REs 
and R-SNA RE, thus far, a typical R-SNA RE in Rab18-mediated 
LD growth has not yet identified. Ykt6 appears to have a very 
minor effect in Rab18-mediated LD sizes, but it was not localized 
to LDs and did not interact with Rab18 either (Fig. 8, I and J). 
This minor effect of Ykt6 may be a result of its regulatory role in 
controlling the assembly and association of ER-associated SNA 
REs with the NRZ complex. A similar role of Ykt6 has been ob-
served in Golgi-ER retrograde transport (Meiringer et al., 2011).
Mechanistically, interaction between LD-associated 
Rab18, NRZ tethering complex, and ER-associated Q-SNA REs 
is able to bring LD and ER within close proximity. We have sev-
eral pieces of evidence to support this. First, our biochemical 
fractionation analysis showed that NRZ proteins and ER-asso-
ciated Q-SNA REs are present in LD fraction in the presence of 
Rab18. Second, fluorescent imaging analysis indicates that NRZ 
and Q-SNA REs are colocalized with Rab18 on the LD sur-
face. Finally and most important, EM analysis using the APEX 
staining technique clearly demonstrated that in the presence of 
Rab18, ER membrane is in close contact with LDs to form spe-
cial ER–LD contact sites. This is consistent with previous ob-
servation that overexpression of Rab18 causes an enwrapping of 
LD by ER membrane (Ozeki et al., 2005).
The cross talk between ER and LD in regulating LD 
growth and maturation has been observed in yeast, where 
nascent LDs seem to be constantly connected with the ER 
(Jacquier et al., 2011) in Caenorhabditis elegans (Xu et al., 
2012b) and in hepatocytes where ApoB is shown to tightly as-
sociate with the LDs (Ohsaki et al., 2008). ER–LD contact is 
also observed in seipin-mediated LD growth (Salo et al., 2016; 
Wang et al., 2016). But the precise molecular nature of such 
contact remains unclear.
What is the precise mechanism of Rab18-NRZ-SNA REs in 
controlling lipid incorporation from ER to LDs for their growth? 
According to the crystal structure of Dsl1 and the speculated struc-
ture of NRZ tethering complex (Ren et al., 2009), we postulate that 
when Rab18-GTP binds to the ZW10 subunit that is localized on 
the top of the NRZ “rod,” it will bind to ER-associated SNA REs, 
resulting in the assembly of Rab18-NRZ-SNA RE complex. As-
sembly of Rab18-NRZ-SNA RE complex results in the tethering 
of ER membrane to LDs to create a direct ER–LD contact. In addi-
tion, Rab18-NRZ-SNA RE complex assembly may provide energy 
for the subsequent deformation of ER bilayer and LD monolayer 
membrane, resulting in a direct transfer of TAG synthesized from 
ER to LDs at the ER and LD interface to promote nascent LD 
growth. Alternatively, Rab18-NRZ-SNA RE complex may control 
phospholipid dynamics or composition in ER–LD interface to fa-
cilitate the distribution of TAG from ER to LDs (Fei et al., 2011; 
Ben M’barek et al., 2017). Finally, Rab18-NRZ-SNA RE com-
plex assembly may allow the recruitment of other proteins to the 
ER–LD contact site to form a special channel or pore to allow the 
incorporation of lipids from ER to LDs (Fig. 10 E). The delineation 
of the Rab18-NRZ-SNA RE regulatory loop holds great promise 
for them to be molecular targets for developing therapeutic drugs 
for lipid storage–related diseases.
Materials and methods
DNA construction and reagents
Full-length cDNAs encoding various mouse proteins were amplified 
by PCR from cDNAs of 3T3-L1 preadipocytes or mouse liver. cDNA 
encoding mouse Rab18 was cloned into pCMV5-HA (Clontech), pC-
MV5-Flag (Clontech), pEGFP-C1 (Clontech), pmCherry-C1 (Clontech), 
or pGEX-6P-1 (GE Healthcare) vectors. Point mutations of Rab18 were 
introduced by a PCR-based site-directed mutagenesis. LiveDrop LD 
marker was generated by cloning sequences encoding the hairpin do-
main of mouse GPAT4 into pEGFP-N1 (Clontech) vector, according to 
previous description (Wang et al., 2016). GFP-CB5 was generated by 
cloning sequences encoding the C-terminal transmembrane domain of 
mouse Cytb5 into pEGFP-C1 vector. cDNA encoding mouse GPAT4 was 
cloned into pEGFP-N1 vector. cDNAs encoding mouse GPAT3, DGAT1, 
and DGAT2 were constructed into pEGFP-C1 vector. cDNAs encoding 
mouse Rab3GAP1 and Rab3GAP2 were cloned into pCMV5-HA or 
pCMV5-Flag vectors. cDNAs encoding mouse ZW10 and RINT1 were 
cloned into pEGFP-C1, pCMV5-HA, or pCMV5-Flag vectors. Full-
length cDNA encoding human NAG was amplified from cDNA libraries 
provided by Jiahuai Han (Xiamen University, Xiamen, China) and cloned 
into pCDNA 3.1(-)-Flag (Invitrogen), pCMV5-HA, or pEGFP-C1 vec-
tors. Truncations of NAG encoding amino acids 734–1355 (Sec39 do-
main) and 1356–2371 were subcloned into pCDNA3.1(-)-Flag vector. 
cDNAs encoding Stx18 and Use1 were cloned into pEGFP-C1 vector. 
cDNA encoding mouse BNIP1 was cloned into pEGFP-N1 vector.
DGAT1 inhibitor (PF-04620110) was purchased from Sell-
eck Chemicals. OAs, TG, free glycerol reagent, triglyceride reagent, 
isoproterenol, IBMX, DGAT2 inhibitor (PF-06424439), M2-agarose 
beads, glutathione, and 3×Flag peptide were purchased from Sigma- 
Aldrich. Protease inhibitor cocktail tablet and protein G agarose beads 
were purchased from Roche. Glutathione agarose beads were from 
GE Healthcare. Free fatty acid (FFA) uptake kit was from Abcam. 
Bodipy 493/503, Bodipy C12, LipidTOX neutral red, and LipidTOX 
deep red were from Life Technologies. Monodansylpentane (MDH) 
was obtained from Abgent.
Antibodies
Antibodies against Fsp27 were described previously (Sun et al., 
2013a; Wu et al., 2014a). Antibodies against HA (mouse, sc-7392), 
Flag (mouse, sc-807), GFP (rabbit, sc-8334), GRP94 (rat, sc-32249), 
RINT1 (goat, sc-19404), Syntaxin18 (mouse, sc-293067), and BNIP1 
(goat, sc-1713) were purchased from Santa Cruz Biotechnology. An-
tibodies against Rab10 (rabbit, 4262), FABP4 (rabbit, 3544) and Bip 
(rabbit, 3177) were obtained from Cell Signaling Technology. Antibod-
ies against NAG (rabbit, ab122370; used for Western blot) and ZW10 
(rabbit, ab21582; used for immunofluorescence [IF]) were obtained 
from Abcam. Antibodies against Rab3GAP1 (rabbit, HPA034495); 
Rab3GAP2 (rabbit, HPA026273), NAG (rabbit, HPA036817; used for 
IF), Use1 (rabbit, HPA047562), and Ykt6 (rabbit, HPA030817) were 
obtained from Human Protein Atlas. Antibodies against Rab18 (mouse, 
60057–1-Ig; used for IF) and ZW10 (rabbit, 24561–1-AP; used for 
Western blot) were obtained from Proteintech. Antibody against ACSL3 
(mouse, H00002181-B0) was obtained from Abnova. Antibodies against 
Rab18 (rabbit, SAB4200173, used for Western blot), Calnexin (rab-
bit, C4731), β-tubulin (mouse, T0198), and actin (mouse, A5441) were 
purchased from Sigma-Aldrich. Antibodies against ADRP (guinea pig, 
20R-Ap002) and Plin1 (guinea pig, 20R-pp004) were purchased from 
Fitzgerald Industries. Antibody against GM130 (mouse, 610822) was ob-
tained from BD Bioscience. Antibody against GST (mouse, AB101) was 
obtained from Tiangen. HRP-conjugated goat anti–mouse or rabbit IgG 
was obtained from GE Healthcare. Alexa Fluor 488/568/647–conjugated 
donkey anti–mouse or rabbit IgG was purchased from Life Technologies.
Cell culture and transfection
293T cells (CRL-3216; ATCC) and 3T3-L1 preadipocytes (CL-173; 
ATCC) were cultured in high-glucose DMEM (Life Technologies) 
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containing 10% FBS (Life Technologies), 2 mM l-glutamine, 100 U/
ml penicillin, and 100 µg/ml streptomycin at 37°C in a humidified in-
cubator containing 5% CO2. TM-3 Leydig cells were obtained from 
ATCC (CRL-1714) and cultured in high-glucose DMEM supplemented 
with 5% FBS and 2.5% horse serum. Monolayers of 3T3-L1 preadipo-
cytes were induced to differentiate into mature adipocytes as described 
by the protocol of ATCC.
Plasmid DNAs were transfected into 293T cells using Lipofect-
amine 2000 according to the manufacturer’s instructions (Invitrogen). 
Electroporation of 3T3-L1 preadipocytes and mature adipocytes was 
performed using Amaxa Nucleofector II (Lonza) with program A-033 
according to the manufacturer’s instructions.
RNA interference
siRNAs were introduced into 3T3-L1 preadipocytes by electropo-
ration as described in the Cell culture and transfection section. Cells 
were then cultured for 48 h and harvested. The knockdown efficiency 
for each protein was evaluated by semiquantitative real-time PCR 
analysis or Western blot analysis. siRNAs used in all experiments 
are listed in Table S2.
Generation of KO cell line using CRI SPR/Cas9
Generation of KO cell lines was performed according to previous 
studies (Ran et al., 2013; Cao et al., 2016). In brief, single guide 
RNAs (sgRNAs) were designed using CHO PCH OP (https ://chopchop 
.rc .fas .harvard .edu /) and constructed into pLentiCRI SPRv1 vector 
(49535; AddGene). Lentivirus were produced by cotransfecting 
pLentiCRI SPRv1 with packaging plasmids pMD2.G (12259; 
AddGene) and psPAX2 (12260; AddGene) into 293T cells. 
Purification of Lentivirus was performed as previously described 
(Nian et al., 2010). 3T3-L1 preadipocytes or TM-3 Leydig cells were 
infected with Lentivirus for 24 h, and were treated with 2 µg/ml of 
puromycin for 4–5 d to select positive clones. The drug-resistant 
cells were then diluted and plated on 96-well dishes to form a single 
colony. KO efficiency of each cell line was determined by Western 
blot analysis. Genomic edition was finally validated by sequencing 
the genomic sequence flanking the targeting sites that were amplified 
using PCR and subcloned to pEASY-T1 (Transgene). sgRNAs used 
for knocking out various genes are shown in Table S3.
Immunostaining
For immunostaining, cells cultured on coverslips were washed twice 
with PBS, fixed with 4% paraformaldehyde for 20 min, and permeabi-
lized with 0.1% saponin for 20 min. Cells were blocked with 10% goat 
serum in PBS supplemented with 0.1% saponin for 1 h and incubated 
with primary antibodies (1:50–1:200 diluted) in PBS supplemented 
with 0.1% saponin overnight at 4°C and then with secondary antibod-
ies (1:500 diluted) for 1 h at room temperature. LDs were stained with 
Bodipy 493/503 (1:200 diluted), LipidTOX (1:300 diluted), or MDH 
(1:500 diluted) in PBS for another 20 min.
Fluorescent imaging
Images were collected on a Nikon A1R+ laser scanning confocal mi-
croscope with CFI Plan Apo 100× oil immersion objective (NA 1.45) 
and 405/488/561/640 laser. GaAsP multidetector photomultiplier tube 
was used to obtain images. For fixed cells, images were acquired at 
room temperature. Images with 1024 × 1024 pixels were obtained with 
4 frames mean. For z-stack images, images (1,024 × 1,024 pixels) with 
0.3 µm per section were obtained. Living cell imaging was performed 
according to a previous study (Sun et al., 2013b). Cells were cultured 
in a living cell station (Oko Lab) at 37°C, 5% CO2, and 80% humidity. 
After loading with 200 µM OA (with 1:1,000 diluted Bodipy 493/503 
or LipidTOX neutral red), images (512 × 512 pixels) were taken in 
2-min intervals for 8  h.  For 3D time-lapse imaging, optical sections 
were obtained with 0.3-µm thickness in every 30 min. NIS-Element 
software (Nikon) was used to obtain images.
Structured illumination microscopy (SIM) images were obtained 
using a Nikon N-SIM superresolution microscope with SR Plan Apo 
100× oil immersion objective (NA 1.49) and Andor iXon 897 EMC 
CD at room temperature.
Transmission electron microscopy
Cells were fixed in 2.5% gluteraldehyde in 0.1 M sodium cacodylate 
buffer, pH 7.4, for 1 h and washed with 0.1 M sodium cacodylate buf-
fer. Cells were then postfixed with 1% OsO4, 1.5% potassium ferrocy-
anide, and 1 mM CaCl2 in 0.1 M sodium cacodylate buffer. Next, the 
cells were dehydrated in a graded series of ethanol, substituted with 
propylene oxide, and infiltrated with the SPON12 resin mixture fol-
lowed by polymerization at 60°C for 24 h. Ultrathin sections were pre-
pared using Lecia Ultracut R. Samples were observed using a Hitachi 
H-7650 transmission electron microscopy at 80 kV.
APEX-EM and quantification
APEX-EM was performed according to the method described in Ariotti 
et al. (2015) and Lam et al. (2015). In brief, cells were washed 3 times 
with 0.1 M sodium cacodylate buffer, and then washed with 1 mg/ml 
DAB/cacodylate mixture for 2 min. Sodium cacodylate buffer supplied 
was 1 mg/ml DAB and 5.88 mM H2O2 were added to the cells for 30 
min at room temperature. After that, the cells were washed three times 
with 0.1 M sodium cacodylate buffer and postfixed with 1% OsO4 in 
0.1 M cacodylate buffer for 2 min.
For quantitative analysis of the percentage of cells containing 
APEX-Stx18–labeled ER–LD contact, 22–39 cells/genotype were ran-
domly selected. A cell that had at least one LD containing APEX-Stx18 
signal on its surface was counted as positive.
For quantitative analysis of the percentage of LDs apposing to 
ER, 11–17 regions of interest (ROIs) from 11–17 cells were randomly 
selected, and 143–363 LDs were evaluated for wild-type, Rab18-over-
expressing, and Rab18-deficient cells. An LD that was closely apposing 
to ER cisternae (within a distance of less than 20 nm) was counted as 
positive. For quantitative analysis of the percentage of LD surface area 
apposing to ER, 11–17 ROIs were randomly selected from 11–17 cells 
per genotype (143–363 LDs). The length of LD surface apposing to ER 
and LD circumference was measured using ImageJ-FIJI. For each LD 
in a ROI, the ratio of the length of LD-ER apposition to the LD circum-
ference was calculated and averaged.
Image processing and analysis
Images were processed in NIS-element or ImageJ. Deconvolution of 
fluorescent images in Fig. 5 C; Fig. S3 (A and I); Fig 6 (G and H); 
Fig. S4 D; Fig. 8 K; and Fig. 9 (B, D, and F) was performed in NIS- 
element. The diameters of the largest LD per cell were measured 
through NIS-element or ImageJ. LD numbers per field and the diam-
eter of LDs in EM images were determined using NIS-element. 3D 
surface reconstitution of LDs was performed in Imaris 8.0 (Bitplanet). 
LDs stained with fluorescent dyes were detected in surface mode using 
background subtraction method, and the numbers, sizes, and volumes 
of LDs were automatically measured.
Measurement of cellular TAG
Cells were loaded with 200 µM OA for 20 h and harvested. Cells were 
scraped from dishes, washed with PBS, and lysed in lipid extraction 
solution (hexane/isopropanol 3:2, vol/vol). After centrifugation at 
1,000 g for 5 min, the upper organic phase was collected and dried 
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with nitrogen gas. Lipids were resuspended in chloroform containing 
1% Triton X-100 and then dried with nitrogen gas. Lipids were finally 
resuspended in water. TAG level was measured using TAG reagent 
(Sigma-Aldrich) and free glycerol reagent (Sigma-Aldrich).
FFA uptake assay
FFA uptake rate was measured using the Free Fatty Acid Uptake Assay 
kit (Abcam). In brief, 3T3-L1 preadipocytes were serum-starved for 
1  h, and then incubated with FA dye-loading solution for 10 min. 
Fluorescence signals were measured using a microplate reader with 
FITC filter (PerkinElmer).
Measurement of lipolysis rates
3T3-L1 preadipocytes were loaded with 200  µM OA and 1 µCi/ml 
[3H]-OA overnight. Cells were rinsed twice with opti-MEM and cul-
tured in opti-MEM containing 1% FA–free BSA for 2 h at 37°C. FA 
released was extracted from medium and measured using a MicroBeta 
Jet (PerkinElmer) liquid scintillation counter.
For lipolysis assay of mature adipocytes, 8-d differentiated 
3T3-L1 adipocytes were washed three times with PBS and then in-
cubated in phenol red–free, serum-free DMEM (Gibco) containing 
1% fatty acid–free BSA (Sigma-Aldrich) in the presence or absence 
of 10  mM isoproterenol and 10  mM IBMX for 4  h.  The amount of 
glycerol released into culture medium was measured by free glycerol 
reagent (Sigma-Aldrich).
Measurement of lipid synthesis rates
3T3-L1 preadipocytes were serum starved overnight, and then incu-
bated with 200 µM OA and 1 µg/ml Bodipy C12 for 0, 30, 60, and 120 
min before harvesting. Lipids were extracted using chloroform/metha-
nol (2:1, vol/vol), loaded onto TLC plates, and separated with hexane/
diethyl ether/acetate (70:30:1, vol/vol). The TLC plate was scanned by 
Typhoon trio+ (GE Healthcare) and the fluorescent intensity of TAG 
spots was measured in ImageJ.
Protein expression and purification
GST-Rab18 was purified from E. coli strain BL21 (DE3). Bacteria that 
were transformed with pGEX-6p-1-Rab18 were grown in LB medium 
containing 100 µg/ml ampicillin to OD 0.6, and induced with 0.01 mM 
IPTG for 12 h at 16°C. Cells were harvested, resuspended, and then 
lysed in lysis buffer (25 mM Tris, pH 7.4, 150 mM NaCl, 1% Triton 
X-100, 1 mM PMSF, 1 mM DTT, and 10% glycerol) by sonication. 
Recombinant protein was first purified using Glutathione Sepharose 4B 
(GE Healthcare) according to the manufacturer’s instructions. Proteins 
were concentrated and further purified by gel filtration chromatography 
(Superdex 200 10/300 GL; GE Healthcare) in 20  mM Tris, pH 7.4, 
100 mM NaCl, 1 mM MgCl2, and 1 mM DTT.
Flag-ZW10 was purified from 293T cells. 8 µg of pC-
MV5-flag-ZW10 plasmid was introduced into each 10-cm dish of 293T 
cells for 24 h. Cells were scraped from dishes and washed with PBS. 
Cells were resuspended in lysis buffer (20 mM Tris, pH 7.4, 150 mM 
NaCl, 1 mM EDTA, and 0.4% CHA PS), supplemented with protease 
inhibitor cocktail (Roche), and then broken by sonication. Cell lysates 
were spun at 12,000 g, and the supernatants were incubated with M2 
beads for 3 h at 4°C. The beads were washed with washing buffer five 
times (20 mM Tris, pH 7.4, 700 mM NaCl, 5 mM EDTA, and 0.4% 
CHA PS), and the protein was eluted with elution buffer (20 mM Tris, 
pH 7.4, 100 mM NaCl, and 100 µg/ml 3×flag peptide).
Protein concentration was determined using the Bradfold method 
(Bio-Rad). The purity of protein was evaluated with Coomassie Bril-
liant Blue (Sigma-aldrich) staining or silver staining.
IP
For IP, cellular protein was extracted with IP buffer (20 mM Tris, pH 
7.4, 100 mM NaCl, 1 mM MgCl2, and 0.4% CHA PS), supplemented 
with protease inhibitor cocktail (Roche). After being centrifuged at 
12,000 g, the supernatants were incubated with M2 beads to pull down 
flag-tagged protein for 3 h at 4°C. The beads were washed with IP buffer 
three times before adding 1.2× laemmli loading buffer. Proteins co-IP 
were analyzed by Western blot. For IP of endogenous protein, antibody 
or preimmune serum premixed with protein G beads (Roche) was used.
For in vitro binding assay, 1.5 µg GST protein or 2.5 µg GST-
Rab18 was loaded with 1 mM GTP-γS or 1 mM GDP in nucleotide 
loading buffer (20  mM Tris, pH 7.4, 100  mM NaCl, 1  mM MgCl2, 
5 mM EDTA, and 0.4% CHA PS) for 1 h at 4°C, followed by adding 
10 mM MgCl2 to stop reaction for 10 min on ice. Next, 2 µg flag-ZW10 
prebound to M2 beads was added to form protein complex with GST-
Rab18 for 2 h at 4°C. The beads were then washed with washing buffer 
(20 mM Tris, pH 7.4, 150 mM NaCl, 10 mM MgCl2, and 0.4% CHA 
PS) three times before the addition of 1.2× laemmli loading buffer.
Subcellular fractionation
Subcellular fractionation was performed according to the method de-
scribed in Ding et al. (2013) and Gong et al. (2011) with slight modifi-
cations. TM-3 cells were harvested, washed with PBS, and resuspended 
in hypotonic buffer (10 mM Hepes, pH 7.8, 1 mM EGTA, and 25 mM 
KCl) for 20 min on ice. Cells were spun down at 600  g for 5 min, 
and the supernatants were discarded. Cells were resuspended with TES 
buffer (20 mM Tris, pH 7.4, 1 mM EDTA, and 250 mM sucrose) and 
homogenized through Dounce homogenizer (Kimble Chase) with loose 
pestle 25 times. The postnuclear supernatants (PNSs) were obtained 
after centrifugation at 1,000 g for 10min. PNS was further centrifuged 
at 12,000 g for 15 min to get postmitochondrial fraction. Floating buf-
fer (100  mM NaCl, 20  mM Tris, pH 7.4, and 1.5  mM MgCl2) was 
laid on postmitochondrial fraction and centrifuged at 200,000 g for 1 h 
using a Beckmann SW41 rotor. The pellet fraction and middle gradient 
were collected as crude microsomal fraction and cytosol, respectively. 
The LDs on the top were collected and washed three times with floating 
buffer. All procedures were performed at 4°C, and protease inhibitors 
were added. Protein concentration was determined using BCA assay 
(Thermo Fisher Scientific). Relative amounts of protein on each frac-
tion were analyzed by Western blot.
Statistics
Data were subjected to statistical analysis and plotted using Graphpad 
Prism 5.0. Statistical calculations to predetermine required sample size 
were not performed. The D’Agostino and Pearson omnibus normality 
test was used to determine the normal distribution of data. For data with 
normal distribution, single comparisons were performed using the two-
tailed Student’s t test, whereas multiple comparisons were assessed by 
one-way ANO VA with the Tukey post hoc test. Dataset that did not 
follow normal distribution were analyzed using nonparametric tests 
(Mann-Whitney test for single comparisons or Kruskal-Wallis test for 
multiple comparisons). For all analyses, a p-value <0.05 was consid-
ered to be statistically significant. Results are reported either by mean 
± SEM or mean ± SD as indicated in the figure legends. The methods 
for calculating p-values are indicated in the figure legends.
Online supplemental material
Fig. S1 shows defective LD growth and maturation in Rab18-deficient 
cells (related to Fig. 1). Fig. S2 shows that TAG synthesis on ER is 
required for Rab18-controled LD growth (related to Fig.  4). Fig. S3 
shows that Rab3GAP1/2 controls the activity and LD localization of 
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Rab18 (related to Fig. 5). Fig. S4 shows that Rab18 binds to NRZ teth-
ering complex (related to Fig. 6). Fig. S5 shows that NRZ complex acts 
as a downstream effector of Rab18 to control LD growth (related to 
Fig. 7). Video 1 shows the time course of LD accumulation in control 
cells. Video  2 shows the time course of LD accumulation in Rab18 
knocked down cells. Video 3 showstime-lapse 3D images of LD accu-
mulation in control cells. Video 4 shows time-lapse 3D images of LD 
accumulation in Rab18 knocked down cells. Video 5 shows time-lapse 
3D images of LD accumulation in control cells. Video 6 shows time-
lapse 3D images of LD accumulation in NAG-deficient cells. Table S1 
shows SNA REs identified from LD fraction isolated from hepatocytes 
of ob/ob mice. Table S2 shows siRNAs used in this work. Table S3 
shows sgRNAs used in this work.
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